ERNAWErnexa Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Ernexa Therapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ERNAW본 종목 | $58930#8 | 0.0x#6 | 0.0x#8 | 0.1x#2 | 755.9%#2 | 68.4%#2 | -1601.2%#3 | -440.1%#11 | -1016.2%#2 | — | — | — |
| PTIX | $1M#3 | 0.5x#8 | 0.8x#9 | — | — | 138.1%#1 | — | 79.4%#1 | — | — | -77.9%#1 | — |
| CDT | $164493#4 | 0.0x#3 | 0.0x#2 | — | — | -120.3%#9 | — | -38.0%#4 | — | — | -100.0%#3 | — |
| SBFMW | $124463#5 | 0.0x#7 | 0.0x#6 | 0.0x#1 | 4.1%#4 | -16.4%#6 | -17.2%#1 | -21.7%#3 | -63.1%#1 | — | — | — |
| CINGW | $117789#6 | — | 0.0x#7 | — | — | -35.6%#7 | — | -95.7%#8 | — | — | — | — |
| KTTAW | $90219#7 | — | 0.0x#3 | 0.2x#3 | 3130.4%#1 | -46.9%#8 | -4286.7%#4 | -41.0%#6 | — | — | -89.9%#2 | — |
| CDTTW | $5271#12 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#9 | — | -38.0%#4 | — | — | — | — |
| ASBPW | $32259#9 | 0.0x#4 | 0.0x#5 | 5.2x#5 | — | -1768.9%#11 | -312016.9%#5 | -208.2%#10 | — | — | — | — |
| REVBW | $24697#10 | 0.0x#5 | 0.0x#4 | — | — | 40.7%#4 | — | -88.5%#7 | — | — | — | — |
| ADTX | $7588#11 | 0.0x#1 | — | 2.4x#4 | -97.6%#5 | -6.8%#5 | -612542.2%#6 | — | — | — | -100.0%#4 | — |
| AAPG | $6.5B#1 | — | 179.1x#11 | 52.1x#6 | — | — | — | -153.5%#9 | — | — | — | — |
| ABUS | $1.0B#2 | 6.4x#9 | 3.9x#10 | 71.1x#7 | 128.2%#3 | 52.1%#3 | -271.0%#2 | -12.9%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice